Brief: Novant Health Initiates Phase 2 Covid-19 Trial With Cytodyn’S Leronlimab
07/04/2020 23:05
Cytodyn Inc CYDY.PK :
* NOVANT HEALTH INITIATES PHASE 2 COVID-19 TRIAL WITH
CYTODYN’S
LERONLIMAB
* CYTODYN INC - IS ALSO INITIATING A SECOND COVID-19 TRIAL
THIS
WEEK
Source text for Eikon: ID:nGNX6c6p49
Further company coverage: CYDY.PK
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer